The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.
Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.
We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.
For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.
That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.
We expanded our universe to include some mid-caps.
To make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.
We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.
Financials went back and kissed the same prices they hit at their peak just before the Great Financial Crisis.
This is easily one of the most important price levels in stock market history. And I heard no one talking about it.
Meanwhile, the Home Construction Index did the exact same thing. In this case, even more special. The peak in Home Construction was when the fund launched, which is both classic and hilarious.
One of the processes we absolutely love to follow is the Top/Down Analysis approach. In this process, we identify the larger trend, zoom in, and analyze the characteristics that stand out. We look at the asset classes, identify the strongest one, and then deep dive. Next, we look at sectors and identify the pockets of outperformance. Finally, we look at an actionable trade that suits our risk and reward parameters.
Our Hall of Famers list is composed of the 150 largest US-based stocks.
These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.
It has all the big names and more.
It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that which you can check out here.
The Hall of Famers is simple.
We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.
Let’s dive right in and check out what these big boys are up to.
As this summer’s relief rally gains momentum, the new highs list is gaining and growing along with it.
For long-only universes like The Hot List, this is great news.
Why?
Because we finally have a good amount of bullish chart setups to choose from again. For a few months there, we were struggling to find solid opportunities for putting on long exposure.
We’ve been patiently waiting for evidence that the market is turning. And while we’re not out of the woods yet, conditions have improved significantly since June.
Let’s dive in and talk about some health care stocks that have our attention right now.